Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label, Randomized Multicenter Study Docetaxel + 5-fluorouracil + Cisplatin Compared to Cisplatin + 5-fluorouracil in Patients With Metastatic or Locally Recurrent Gastric Cancer Previously Untreated With Chemotherapy for Advanced Disease

NCT00811447 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00811447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00811447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label, Randomized Multicenter Study Docetaxel + 5-fluorouracil + Cisplatin Compared to Cisplatin + 5-fluorouracil in Patients With Metastatic or Locally Recurrent Gastric Cancer Previously Untreated With Chemotherapy for Advanced Disease
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2008
Completion date
June 30, 2012
Enrollment
243 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stomach neoplasms